Literature DB >> 33628094

Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway.

Jinqiu Zhao1, Bin He2, Shujun Zhang1, Wenxiang Huang1, Xiaosong Li3.   

Abstract

Background: Severe hepatitis is a common cause of chronic or acute liver disease and autophagy might play an important role in cellular response to inflammation and injury. It has been reported that Ginsenoside-Rg1 (G-Rg1) has strong hepatoprotective effects for acute liver injury, but its protective mechanisms have not yet been elucidated. This study aims to explore the detailed molecular mechanisms of G-Rg1 on acute liver injury via autophagy.
Methods: The role of G-Rg1 by autophagic induction was studied in the mouse model of acute liver injury which induced by carbon tetrachloride (CCl4). Liver function, inflammatory reaction and apoptosis were detected when autophagy has been inhibited by 3-MA or stimulated by RPA. MCC950 and ATP were applied to investigate the role of NLRP3 inflammasome in acute liver injury. The differential expression of NF-κB, NLRP3 inflammasome, caspase 1, caspase 3, IL-1β, IL-18, LC3-I, LC3-II, Beclin-1, PINK1 and Parkin have been detected by the quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot.
Results: G-Rg1 could decrease ALT, AST, TNF-α, IL-1β and IL-6 in mice with CCl4-induced acute liver injury. The change of autophagy and apoptosis after the treatment of 3-MA or RPA demonstrated that the autophagy played a key role in the protective effect of G-Rg1 in acute liver injury. The enhancement of G-Rg1 promoted-autophagy resulted in the significant decrease in NF-κB, NLRP3 inflammasome, caspase 1, caspase 3, IL-1β and IL-18, which suggesting that NF-κB/NLRP3 inflammasome signaling pathway was associated with the autophagy induced by G-Rg1 in acute liver injury.
Conclusion: G-Rg1 ameliorated acute liver injury via the autophagy, which may be related to NF-κB/NLRP3 inflammasome signaling pathway. © The author(s).

Entities:  

Keywords:  Ginsenoside-Rg1; NF-κB; NLRP3 inflammasome.; acute liver injury; autophagy

Year:  2021        PMID: 33628094      PMCID: PMC7893561          DOI: 10.7150/ijms.50919

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  5 in total

Review 1.  Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Sandra Torres; Paula Segalés; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

Review 2.  Potential benefits of ginseng against COVID-19 by targeting inflammasomes.

Authors:  Young-Su Yi
Journal:  J Ginseng Res       Date:  2022-04-04       Impact factor: 5.735

3.  Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway.

Authors:  Xiujing Dou; Di Yan; Siqi Liu; Lujia Gao; Anshan Shan
Journal:  Nutrients       Date:  2022-07-08       Impact factor: 6.706

4.  Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification.

Authors:  Yanqiu He; Cheng Hu; Shiyu Liu; Mingjie Xu; Ge Liang; Dan Du; Tingting Liu; Fei Cai; Zhiyao Chen; Qingyuan Tan; Lihui Deng; Qing Xia
Journal:  Drug Des Devel Ther       Date:  2022-08-02       Impact factor: 4.319

5.  Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice.

Authors:  Yan Li; Duoduo Zhang; Lan Li; Yuli Han; Xianan Dong; Liu Yang; Xuewang Li; Weizu Li; Weiping Li
Journal:  Mol Med Rep       Date:  2021-09-15       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.